Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data" [Molecular Genetics and Metabolism 141, Issue 3 (2024) 108122].
Rohr F, Burton B, Dee A, Harding CO, Lilienstein J, Lindstrom K, MacLeod E, Rose S, Singh R, van Calcar S, Whitehall K. Rohr F, et al. Among authors: whitehall k. Mol Genet Metab. 2024 Dec;143(4):108613. doi: 10.1016/j.ymgme.2024.108613. Epub 2024 Nov 26. Mol Genet Metab. 2024. PMID: 39591708 Free article. No abstract available.
Meta-analysis of bone mineral density in adults with phenylketonuria.
Rocha JC, Hermida Á, Jones CJ, Wu Y, Clague GE, Rose S, Whitehall KB, Ahring KK, Pessoa ALS, Harding CO, Rohr F, Inwood A, Longo N, Muntau AC, Sivri S, Maillot F. Rocha JC, et al. Among authors: whitehall kb. Orphanet J Rare Dis. 2024 Sep 12;19(1):338. doi: 10.1186/s13023-024-03223-9. Orphanet J Rare Dis. 2024. PMID: 39267130 Free PMC article.
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.
Whitehall KB, Rose S, Clague GE, Ahring KK, Bilder DA, Harding CO, Hermida Á, Inwood A, Longo N, Maillot F, Muntau AC, Pessoa ALS, Rocha JC, Rohr F, Sivri S, Said J, Oshinbolu S, Sibbring GC. Whitehall KB, et al. Orphanet J Rare Dis. 2024 Aug 12;19(1):293. doi: 10.1186/s13023-024-03203-z. Orphanet J Rare Dis. 2024. PMID: 39135125 Free PMC article. Review.
Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data.
Lah M, Cook K, Gomes DA, Liu S, Tabatabaeepour N, Kirson N, Chen E, Lindstrom K, Whitehall KB, Van Backle J, Burton BK. Lah M, et al. Among authors: whitehall kb. Mol Genet Metab Rep. 2022 Sep 25;33:100918. doi: 10.1016/j.ymgmr.2022.100918. eCollection 2022 Dec. Mol Genet Metab Rep. 2022. PMID: 36176956 Free PMC article.
Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics.
Adams D, Andersson HC, Bausell H, Crivelly K, Eggerding C, Lah M, Lilienstein J, Lindstrom K, McNutt M, Ray JW, Saavedra H, Sacharow S, Starin D, Tiffany-Amaro J, Thomas J, Vucko E, Wessenberg LB, Whitehall K. Adams D, et al. Among authors: whitehall k. Mol Genet Metab Rep. 2021 Aug 14;28:100790. doi: 10.1016/j.ymgmr.2021.100790. eCollection 2021 Sep. Mol Genet Metab Rep. 2021. PMID: 34430209 Free PMC article.
Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis.
Waisbren S, Burton BK, Feigenbaum A, Konczal LL, Lilienstein J, McCandless SE, Rowell R, Sanchez-Valle A, Whitehall KB, Longo N. Waisbren S, et al. Among authors: whitehall kb. Mol Genet Metab. 2021 Feb;132(2):119-127. doi: 10.1016/j.ymgme.2021.01.001. Epub 2021 Jan 13. Mol Genet Metab. 2021. PMID: 33485801 Free PMC article.